Immunomodulatory effects of bone marrow versus adipose tissue‐derived mesenchymal stromal cells on NK cells: implications in the transplantation setting

B. Blanco,M. C. Herrero-Sánchez,Concepción Rodríguez‐Serrano,María Lourdes García‐Martínez,J. Blanco,S. Muntión,M. García-Arranz,F. Sanchez-Guijo,C. Cañizo
DOI: https://doi.org/10.1111/ejh.12765
2016-06-01
European Journal Of Haematology
Abstract:The ability of mesenchymal stromal cells (MSC) to suppress T‐cell function has prompted their therapeutic use for graft‐versus‐host disease (GVHD) control. However, as MSC also modulate the activity of NK cells, which play an important role in graft‐versus‐leukemia (GVL) reaction, their administration could hamper this beneficial effect of allogeneic hematopoietic stem cell transplantation. MSC can be expanded from several sources, especially bone marrow and fat, but it is not well established if the cell source makes a difference in their immunoregulatory capacity.
What problem does this paper attempt to address?